loading
前日終値:
$3.88
開ける:
$3.8
24時間の取引高:
2,332
Relative Volume:
0.10
時価総額:
$66.03M
収益:
-
当期純損益:
$-12.63M
株価収益率:
-5.2002
EPS:
-0.6942
ネットキャッシュフロー:
$-12.18M
1週間 パフォーマンス:
-9.07%
1か月 パフォーマンス:
-6.48%
6か月 パフォーマンス:
-17.95%
1年 パフォーマンス:
+9.07%
1日の値動き範囲:
Value
$3.61
$3.90
1週間の範囲:
Value
$3.61
$4.15
52週間の値動き範囲:
Value
$2.20
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
名前
Genenta Science Spa Adr
Name
セクター
Healthcare (1162)
Name
電話
-
Name
住所
-
Name
職員
13
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
GNTA's Discussions on Twitter

GNTA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GNTA
Genenta Science Spa Adr
3.61 66.03M 0 -12.63M -12.18M -0.6942
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-06-29 再開されました ROTH MKM Buy
2022-07-25 開始されました H.C. Wainwright Buy
2022-01-13 開始されました Maxim Group Buy

Genenta Science Spa Adr (GNTA) 最新ニュース

pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Mar 19, 2025
pulisher
Jan 10, 2025

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Jan 10, 2025
pulisher
Jan 09, 2025

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewswire Inc.

Jan 09, 2025
pulisher
Dec 30, 2024

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Dec 30, 2024
pulisher
Dec 20, 2024

Genenta Science Updates ATM Sales Agreement with New Agent - TipRanks

Dec 20, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading resumes - TipRanks

Nov 29, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading halted, volatility trading pause - TipRanks

Nov 29, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $30M To Consider - Yahoo Finance

Nov 13, 2024
pulisher
Oct 23, 2024

Genenta Science CEO to present at U.S. Senate meeting - TipRanks

Oct 23, 2024
pulisher
Oct 03, 2024

Genenta Science receives Buy rating amid trial approval - Investing.com

Oct 03, 2024
pulisher
Apr 02, 2024

Genenta Science Announces Shareholder Meeting - TipRanks

Apr 02, 2024
pulisher
Mar 26, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 26, 2024
pulisher
Mar 04, 2024

DHR Stock Quote Price and Forecast - CNN

Mar 04, 2024
pulisher
Jun 05, 2015

Danaher (DHR) Stock Price, News & Analysis - MarketBeat

Jun 05, 2015

Genenta Science Spa Adr (GNTA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):